NCT00220831View on ClinicalTrials.gov

Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

December 31, 2009

Conditions
DiabetesMyocardial InfarctionCardiovascular Disease
Interventions
DRUG

Natural source Vitamin E 400IU/day

Trial Locations (1)

Unknown

Clalit Health Services, Haifa and West Galilee - primary health care clinics, in the north of Israel And the Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Haifa

Sponsors

Collaborators (1)

Clalit Health Services
All Listed Sponsors
collaborator

Clalit Health Services

OTHER

collaborator

The Kennedy Leigh Charitable Trust

OTHER

lead

Technion, Israel Institute of Technology

OTHER

NCT00220831 - Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment | Biotech Hunter | Biotech Hunter